Transactions
7
Insider / U S PHYSICAL THERAPY INC /NV
REEVE GRAHAM D.
COO at U S PHYSICAL THERAPY INC /NV
- Company
- U S PHYSICAL THERAPY INC /NV
- Ticker
- USPH
- First filing on record
- November 25, 2025
- Latest trade on record
- August 20, 2026
- SEC filings
- EDGAR ↗
REEVE GRAHAM D., COO at U S PHYSICAL THERAPY INC /NV, has disclosed 7 transactions in USPH since November 25, 2025: 0 purchases (0 open-market buys) and 6 sales, worth about $361K at the reported prices. The latest was filed August 24, 2026, 4 days after the trade; 2 filings were late against the 2-business-day Form 4 deadline.
Open-market buys
0
Sales
6
Avg. disclosure lag
6.9d
Trading in charts
Trade timeline
When does this person trade, how big, and in which direction? Every trade in the last 12 months.
Bought (above the line)Sold (below the line)Other transaction
In the last 12 months REEVE GRAHAM D. made no purchases and 6 sales worth $361K, plus 1 other transaction. Dot size is the dollar amount.
Portfolio mix
Which stocks does this person trade most? Tile size is dollars traded, all time on record.
REEVE GRAHAM D. has traded 1 stock on record; the largest by dollars is USPH.
Reporting lag
Does this person report on time? One bar per filing against the Form 4 deadline.
On timeLate
2 of 6 filings on record were reported after the Form 4 deadline (two business days, counted here as 4 calendar days).
What kind of transactions
Most Form 4 rows are pay arriving or tax being withheld, not a decision to buy or sell. Only code P is an open-market purchase and code S an open-market sale. What each code means: Form 4 transaction codes.
| Code | Meaning | Rows | Shares | Value |
|---|---|---|---|---|
| S | Open-market sale | 4 | 3,213 | $254K |
| F | Shares withheld for tax | 2 | 1,524 | $107K |
| A | Grant or award | 1 | 10,000 | — |
| Year | Rows | Bought | Sold |
|---|---|---|---|
| 2026 | 6 | 0 | 5 · $308K |
| 2025 | 1 | 0 | 1 · $53K |
Transactions
| Security | Side | Trade date | Disclosed | Lag | Shares | Price | Value | Flags | Source | Share |
|---|---|---|---|---|---|---|---|---|---|---|
| USPH | Sell F | August 20, 2026 | August 24, 2026 | 4d | 762 | $78 | $59K | Form 4 ↗ | ||
| USPH | Sell F | May 20, 2026 | June 22, 2026 | 33d | 762 | $62 | $47K | late | Form 4 ↗ | |
| USPH | Sell S | March 11, 2026 | March 12, 2026 | 1d | 662 | $79 | $52K | Form 4 ↗ | ||
| USPH | Sell S | March 9, 2026 | March 11, 2026 | 2d | 1 | $79 | $79 | indirect | Form 4 ↗ | |
| USPH | Sell S | March 6, 2026 | March 11, 2026 | 5d | 1,807 | $82 | $149K | lateindirect | Form 4 ↗ | |
| USPH | Other A | February 23, 2026 | February 25, 2026 | 2d | 10,000 | — | — | Form 4 ↗ | ||
| USPH | Sell S | November 24, 2025 | November 25, 2025 | 1d | 743 | $71 | $53K | Form 4 ↗ |
Filings
| Filed | Form | Accession | Rows | Status | Source |
|---|---|---|---|---|---|
| August 24, 2026 | Form 4 | 0001193125-26-363888 | 1 | published | EDGAR ↗ |
| June 22, 2026 | Form 4 | 0001193125-26-277646 | 1 | published | EDGAR ↗ |
| March 12, 2026 | Form 4 | 0001193125-26-104315 | 1 | published | EDGAR ↗ |
| March 11, 2026 | Form 4 | 0001193125-26-102296 | 2 | published | EDGAR ↗ |
| February 25, 2026 | Form 4 | 0001193125-26-072703 | 1 | published | EDGAR ↗ |
| November 25, 2025 | Form 4 | 0001193125-25-297192 | 1 | published | EDGAR ↗ |
Other insiders at U S PHYSICAL THERAPY INC /NV
- Harris Bernard A Jr Director 7 rows
- Minan Peter Francis Director 5 rows
- Binstein Richard EVP Gen'l Counsel & Secretary 3 rows
- CURTIS JASON TRAVIS Interim CFO 2 rows
- Gilmartin Kathleen A Director 2 rows
- HENDRICKSON CAREY P Chief Financial Officer 2 rows
- Motsenbocker Anne Director 2 rows
- Williams Eric Joseph President and COO 2 rows
- Davis Myra Director 1 row
- Etta Nchacha EVP & Chief Financial Officer 1 row
Everyone on file, with contracts and lobbying under the company's name: U S PHYSICAL THERAPY INC /NV.
Guides for this page
- What is SEC Form 4? Who files: officers, directors and owners of more than 10% of a class of the company's shares.
- Form 4 transaction codes P = purchase. S = sale. These are the two market trades.
- Insider buying vs insider selling Selling outweighs buying by a wide margin in normal times.
- What disclosure data cannot tell you Filings are late by design: up to 45 days for Congress, two business days for insiders.
Sources and method
| Source | Filings | Rows | First filed | Newest filed | Read the originals |
|---|---|---|---|---|---|
| SEC EDGAR, Form 4 | 6 | 7 | November 25, 2025 | August 24, 2026 | Form 4 list on EDGAR |
Site built October 22, 2026. Every row in the tables above links to its own filing. To quote a figure, use the Cite button at the top of the page; see how to cite and reuse.
Every row comes from the reporting owner's Form 4 as filed with the SEC (EDGAR ownership XML), read daily. "Value" is shares × the reported price; code P is an open-market purchase, S a sale, M an option exercise, A a grant. The lag is the filing date minus the trade date; Form 4 is due within two business days. Amendments (4/A) are not merged. Details on the methodology page; report an error on corrections.
Not investment advice. Figures are public disclosures shown as filed; they may lag the trade and may be amended later. No recommendation is made or implied.